Dexcom
Angela Steinway is an accomplished executive with extensive experience in corporate development, strategy, and finance within the medical technology industry. Currently serving as VP of Corporate Development at Dexcom since June 2023, Angela leads corporate partnerships for diabetes management innovations. As a Board Member and Treasurer at ProduceGood, Angela oversees governance and financial reviews to promote sustainability and reduce food waste. Previously, Angela held various leadership roles at Integra LifeSciences, including Vice President of Strategy, where responsibilities encompassed global division management and business development. Additionally, Angela has been involved as a Board Member on the Audit Committee at SeaSpine and has experience as an analyst at Oppenheimer & Co. and Johnson & Johnson. Angela holds a Bachelor's degree in Economics from the University of Pennsylvania and completed an Executive Education Program at The Wharton School.
Dexcom
43 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.